| 23/323 |
Pagers |
| 23/322 |
NHS Charging of Overseas Visitors |
| 23/320 |
CACNA1C Gene Change |
| 23/319 |
Overseas Recruitment of Clinical Staff |
| 23/318 |
Solar Technology Product |
| 23/317 |
Ovarian Cancer Treatment |
| 23/316 |
Histology Services |
| 23/314 |
Sexual Assaults in Hospitals |
| 23/313 |
Occupational Health |
| 23/312 |
NHS E-Rostering Capabilities |
| 23/310 |
Adverse Events Reporting Rates |
| 23/308 |
Staff Panic Alarms Purchase |
| 23/306 |
Intra-vitreal Injections or Implants |
| 23/304 |
Pharmacy & Multiple Sclerosis |
| 23/303 |
Use of Postal Services by ESHT |
| 23/300 |
Biologic Medicines in Dermatology |
| 23/299 |
Community Trust Service |
| 23/298 |
Thyroid Medications & Reproductive Medication |
| 23/297 |
Fibromyalgia |
| 23/295 |
Usage of Biologic and Biosimilar Products |
